Kiniksa Pharmaceuticals International, plc Earnings Per Share, Basic and Diluted
Kiniksa Pharmaceuticals International, plc (KNSA) reported Earnings Per Share, Basic and Diluted of -$0.44 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-04
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.44.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.61.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.72.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.79.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for fiscal 2020 was -$2.61.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for fiscal 2019 was -$2.99.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for fiscal 2018 was -$3.49.
- Kiniksa Pharmaceuticals International, plc earnings per share, basic and diluted for fiscal 2017 was -$35.85.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2021-09-30 | -$0.44 10-Q · filed 2021-11-04 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.78 10-Q · filed 2021-11-04 | -$2.56 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||
| 2021-06-30 | -$0.61 10-Q · filed 2021-08-05 | -$1.33 10-Q · filed 2021-08-05 | -$2.12 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.79 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||
| 2021-03-31 | -$0.72 10-Q · filed 2021-05-06 | -$1.51 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.18 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.83 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||
| 2020-12-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.11 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.61 10-K · filed 2021-02-25 | ||
| 2020-09-30 | -$0.66 10-Q · filed 2021-11-04 | -$1.31 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$1.80 10-Q · filed 2021-11-04 | -$2.38 derived: net income ÷ weighted average shares · filed 2022-02-24 | ||
| 2020-06-30 | -$0.65 10-Q · filed 2021-08-05 | -$1.13 10-Q · filed 2021-08-05 | -$1.71 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.20 derived: net income ÷ weighted average shares · filed 2022-02-24 | ||
| 2020-03-31 | -$0.48 10-Q · filed 2021-05-06 | -$1.06 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.55 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.23 derived: net income ÷ weighted average shares · filed 2022-02-24 | ||
| 2019-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.75 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.99 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$0.49 10-Q · filed 2020-11-05 | -$1.18 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$2.42 10-Q · filed 2020-11-05 | -$3.29 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||
| 2019-06-30 | -$0.68 10-Q · filed 2020-08-04 | -$1.94 10-Q · filed 2020-08-04 | -$2.82 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.35 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||
| 2019-03-31 | -$1.27 10-Q · filed 2020-05-04 | -$2.16 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.68 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.67 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||
| 2018-12-31 | -$0.87 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.27 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.49 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$0.51 10-Q · filed 2019-11-05 | -$1.34 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$2.62 10-Q · filed 2019-11-05 | -$5.24 derived: net income ÷ weighted average shares · filed 2019-11-05 | ||
| 2018-06-30 | -$1.11 10-Q · filed 2019-08-13 | -$0.97 10-Q · filed 2018-08-06 | -$3.45 10-Q · filed 2019-08-13 | -$3.09 10-Q · filed 2018-08-06 | -$8.98 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$13.62 derived: net income ÷ weighted average shares · filed 2019-11-05 |
| 2018-03-31 | -$6.45 10-Q · filed 2019-05-07 | -$20.75 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$29.26 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$36.55 derived: net income ÷ weighted average shares · filed 2019-11-05 | ||
| 2017-12-31 | -$14.77 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$23.45 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$30.84 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$35.85 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$8.25 10-Q · filed 2018-11-06 | -$15.06 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$19.21 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$6.69 10-Q · filed 2018-08-06 | -$10.47 10-Q · filed 2018-08-06 |